Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Shares Repurchased (2017 - 2025)

Usana Health Sciences has reported Shares Repurchased over the past 14 years, most recently at $15.2 million for Q2 2025.

  • Quarterly Shares Repurchased changed N/A to $15.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $15.2 million through Apr 2026, up 23.63% year-over-year, with the annual reading at $27.5 million for FY2026, 191.26% up from the prior year.
  • Shares Repurchased was $15.2 million for Q2 2025 at Usana Health Sciences, up from $12.3 million in the prior quarter.
  • Over five years, Shares Repurchased peaked at $120.8 million in Q1 2022 and troughed at $9.4 million in Q1 2024.
  • The 5-year median for Shares Repurchased is $15.2 million (2025), against an average of $37.5 million.
  • Year-over-year, Shares Repurchased crashed 62.46% in 2022 and then surged 30.24% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $67.6 million in 2021, then crashed by 62.46% to $25.4 million in 2022, then tumbled by 54.3% to $11.6 million in 2023, then dropped by 18.58% to $9.4 million in 2024, then skyrocketed by 61.02% to $15.2 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Shares Repurchased are $15.2 million (Q2 2025), $12.3 million (Q1 2025), and $9.4 million (Q1 2024).